Neurogenetics, NYU at Rivergate — New York, New York

Neurogenetics, NYU at Rivergate is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Neurogenetics, NYU at Rivergate has participated in 3 clinical trials.

Therapeutic areas: Gaucher Disease.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neurogenetics, NYU at Rivergate?

Neurogenetics, NYU at Rivergate has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neurogenetics, NYU at Rivergate conducted?

Neurogenetics, NYU at Rivergate has 3 clinical trials on record. Their work covers Gaucher Disease.

Is Neurogenetics, NYU at Rivergate accredited by Crixeo Health?

Neurogenetics, NYU at Rivergate has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neurogenetics, NYU at Rivergate?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.